ConvaTec Group PLC (LSE:CTEC)
£ 2.644 0.478 (22.07%) Market Cap: 5.41 Bil Enterprise Value: 6.43 Bil PE Ratio: 37.34 PB Ratio: 3.41 GF Score: 74/100

Q1 2021 ConvaTec Group PLC Trading Statement Call Transcript

Apr 29, 2021 / 07:00AM GMT
Release Date Price: £2.15 (+3.66%)
Operator

Ladies and gentlemen, hello, and welcome to the ConvaTec Group Plc Q1 trading update for the 3 months ended 31st of March 2021. My name is Maxine, and I'll be coordinating the call today. (Operator Instructions)

I will now hand over to your host, Frank Schulkes, CFO, to begin. Frank, please go ahead when you're ready.

Frank M. Schulkes
ConvaTec Group Plc - CFO & Director

Thank you very much, Maxine. Good morning, everyone, and thanks for joining us today. It's a busy morning of reporting. So I will make a few opening remarks, and then we can open it up for questions.

As well as delivering a strong performance during the first quarter, we continued to make good progress with our strategy as we pivot to sustainable and profitable growth, most notably with the acquisition of Cure Medical. The business, which is based in California, develops, manufactures and distributes intermittent catheters. And consistent with the focus and innovate pillars of our strategy, we are investing in the United States as well as enhancing our portfolio in one

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot